Bausch Health Companies Inc. balance sheet
At the end of fiscal 2025, Bausch Health Companies Inc. had total assets of $26.37bn, total liabilities of $25.99bn and shareholders' equity of −$554m. It held $1.31bn in cash against $20.82bn of debt: net debt of $19.51bn.
Balance sheet
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.1 | 0.4 | 0.2 | 0.9 | 0.6 | 0.3 | 0.6 | 0.5 | 0.7 | 0.7 | 3.2 | 0.6 | 0.6 | 0.6 | 0.9 | 1.2 | 1.3 | 2.5 |
| Receivables | 0.1 | 0.2 | 0.5 | 0.8 | 1.7 | 2.1 | 2.7 | 2.5 | 2.1 | 1.9 | 1.8 | 1.6 | 1.8 | 1.8 | 2.0 | 2.1 | 2.4 | 2.5 |
| Inventory | 0.1 | 0.2 | 0.4 | 0.5 | 0.9 | 0.9 | 1.3 | 1.1 | 1.0 | 0.9 | 1.1 | 1.1 | 1.0 | 1.1 | 1.5 | 1.6 | 1.6 | 1.6 |
| Total current assets | 0.3 | 1.0 | 1.4 | 2.8 | 3.9 | 4.1 | 5.5 | 5.1 | 4.7 | 4.2 | 7.0 | 5.3 | 5.6 | 4.2 | 5.6 | 5.8 | 6.2 | 7.4 |
| Goodwill | 0.1 | 3.0 | 3.6 | 5.1 | 9.8 | 9.4 | 18.6 | 15.8 | 15.6 | 13.1 | 13.1 | 13.0 | 12.5 | 11.5 | 11.2 | 11.1 | 11.3 | 9.8 |
| Total assets | 2.1 | 10.8 | 13.1 | 18.0 | 27.9 | 26.3 | 49.0 | 43.5 | 37.5 | 32.5 | 33.9 | 31.2 | 29.2 | 25.7 | 27.4 | 26.5 | 26.4 | 25.5 |
| Accounts payable | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.4 | 0.4 | 0.3 | 0.4 | 0.4 | 0.5 | 0.3 | 0.4 | 0.5 | 0.7 | 0.6 | 0.6 | 0.5 |
| Deferred revenue (current) | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total current liabilities | 0.2 | 0.7 | 0.9 | 1.8 | 2.5 | 2.7 | 5.3 | 3.6 | 4.3 | 3.8 | 6.2 | 4.9 | 5.2 | 3.9 | 4.3 | 6.8 | 4.2 | 4.7 |
| Short-term debt | 0.0 | 0.1 | 0.1 | 0.5 | 0.2 | 0.0 | 0.8 | 0.0 | 0.2 | 0.2 | 1.2 | 0.0 | 0.0 | 0.4 | 0.5 | 2.7 | 0.2 | 0.9 |
| Long-term debt | 0.3 | 3.5 | 6.5 | 10.5 | 17.2 | 15.2 | 30.3 | 29.8 | 25.2 | 24.1 | 24.7 | 23.9 | 22.7 | 20.3 | 21.9 | 18.9 | 20.6 | 19.8 |
| Total debt | 0.3 | 3.6 | 6.7 | 11.1 | 17.6 | 15.4 | 31.4 | 30.2 | 25.8 | 24.6 | 26.2 | 24.2 | 22.9 | 20.8 | 22.4 | 21.6 | 20.8 | 20.6 |
| Total liabilities | 0.7 | 5.9 | 9.2 | 14.2 | 22.7 | 20.9 | 42.9 | 40.3 | 31.6 | 29.7 | 32.7 | 30.6 | 29.2 | 25.4 | 27.4 | 26.8 | 26.0 | 25.8 |
| Shareholders' equity | 1.4 | 4.9 | 3.9 | 3.7 | 5.1 | 5.3 | 5.9 | 3.2 | 5.8 | 2.7 | 1.1 | 0.5 | −0.1 | −0.7 | −1.0 | −1.3 | −0.6 | −1.3 |
| Non-controlling interests and other (assets − liabilities − equity) | — | — | — | — | — | — | — | — | — | — | — | — | — | 1.0 | 0.9 | 1.0 | 0.9 | 1.0 |
| Net debt (negative = net cash) | 0.2 | 3.2 | 6.5 | 10.2 | 17.0 | 15.1 | 30.8 | 29.6 | 25.0 | 23.9 | 22.9 | 23.6 | 22.3 | 20.2 | 21.4 | 20.4 | 19.5 | 18.2 |
| Shares outstanding | 158m | — | 306m | 304m | 333m | 334m | 343m | 348m | 349m | 350m | 353m | 355m | 359m | 362m | 365m | 368m | 371m | 374m |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 2.1 | 2.1 | 2.2 | 2.4 | 2.4 | 2.2 | 2.3 | 2.5 |
| Inventory | 1.6 | 1.6 | 1.7 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 |
| Total current assets | 5.8 | 5.7 | 6.5 | 6.2 | 6.2 | 6.0 | 6.5 | 7.4 |
| Goodwill | 11.1 | 11.2 | 11.3 | 11.3 | 11.3 | 9.8 | 9.8 | 9.8 |
| Total assets | 26.5 | 26.4 | 27.3 | 26.8 | 26.4 | 24.5 | 24.8 | 25.5 |
| Accounts payable | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 |
| Total current liabilities | 6.8 | 4.3 | 5.0 | 4.8 | 4.2 | 4.5 | 4.5 | 4.7 |
| Short-term debt | 2.7 | 0.3 | 0.9 | 0.6 | 0.2 | 0.9 | 0.9 | 0.9 |
| Long-term debt | 18.9 | 21.2 | 20.9 | 20.5 | 20.6 | 19.9 | 19.9 | 19.8 |
| Total debt | 21.6 | 21.5 | 21.7 | 21.0 | 20.8 | 20.8 | 20.7 | 20.6 |
| Total liabilities | 26.8 | 26.7 | 27.1 | 26.5 | 26.0 | 25.6 | 25.6 | 25.8 |
| Shareholders' equity | −1.3 | −1.2 | −0.8 | −0.6 | −0.6 | −2.1 | −1.8 | −1.3 |
| Non-controlling interests and other (assets − liabilities − equity) | 1.0 | 0.9 | 0.9 | 0.9 | 0.9 | 1.0 | 1.0 | 1.0 |
| Shares outstanding | 368m | 370m | 370m | 370m | 371m | 373m | 374m | 374m |
Compare with peers
- Zoetis balance sheet
- Haleon plc balance sheet
- Viatris balance sheet
- Universe Pharmaceuticals Inc balance sheet
- Organon & Co. balance sheet
Head to head: BHC vs ZTSBHC vs HLNBHC vs VTRSBHC vs UPC
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies